TherapeuticsMD, Inc. Operating Lease Right-of-Use Assets
TherapeuticsMD, Inc. (TXMD) had Operating Lease Right-of-Use Assets of $4.83 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-11
- 2026-06-30: Operating Lease, Right-of-Use Asset $4.83M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $5.06M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $5.29M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $5.51M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $4.83M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $5.06M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $5.29M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $5.51M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $5.73M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.95M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $6.10M 10-K/A · filed 2026-04-01 | |
| 2024-06-30 | $6.50M 10-Q · filed 2024-08-12 | |
| 2023-12-31 | $6.87M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $7.05M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $7.23M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.41M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $7.58M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $7.75M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $7.91M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $8.07M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $8.23M 10-K · filed 2023-04-07 | |
| 2021-09-30 | $8.39M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $8.84M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $9.21M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $9.57M 10-K · filed 2022-03-23 | $9.57M 10-K · filed 2021-03-04 |
| 2020-09-30 | $9.98M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $10.34M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $9.76M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $10.11M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $10.46M 10-Q · filed 2019-11-08 | |
| 2019-08-31 | $7.40M 10-K · filed 2020-02-24 | |
| 2019-06-30 | $3.32M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.54M 10-Q · filed 2019-05-08 | |
| 2019-01-02 | $3.80M 10-Q · filed 2019-11-08 | |
| 2019-01-01 | $3.80M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |